A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation
Completed
EMD Serono
Phase 4
2003-09-01
To demonstrate the comparative safety and efficacy of Cetrotide® 3 milligram (mg) and
Antagon™ in the inhibition of a premature luteinizing hormone (LH) surge in women undergoing
ovarian stimulation with recombinant human follicle stimulating hormone/human menopausal
gonadotropin (r-hFSH/hMG) prior to assisted reproductive technology (ART) and utilizing oral
contraceptives pill (OCP) for cycle programming.
Synchronization of Follicle Wave Emergence and Ovarian Stimulation
Completed
Royal University Hospital Foundation
Phase 4
2007-02-01
The objective of the study is to elucidate the effect of synchronizing initiation of ovarian
stimulation treatment with follicular wave emergence in poor responder patients undergoing
IVF/ICSI and ET. We hypothesize that initiating treatment on day 1 versus day 4 of the cycle
will increase the number of follicles recruited and oocytes retrieved.
Synchronization of Follicle Wave Emergence and Ovarian Stimulation
Completed
University of Saskatchewan
Phase 4
2007-02-01
The objective of the study is to elucidate the effect of synchronizing initiation of ovarian
stimulation treatment with follicular wave emergence in poor responder patients undergoing
IVF/ICSI and ET. We hypothesize that initiating treatment on day 1 versus day 4 of the cycle
will increase the number of follicles recruited and oocytes retrieved.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
